글로벌 점액선모 청소 및 기능 장애 치료 시장 – 2029년까지의 산업 동향 및 예측

글로벌 점액선모 청소 및 기능 장애 치료 시장 분석 및 통찰력

만성 폐쇄성 폐질환 및 기타 호흡기 질환의 부담이 증가함에 따라 점액선모기능 장애가 더욱 발생하여 전 세계적으로 시장 성장이 촉진됩니다. 점액선모 청소에 대한 효과적인 치료법 채택이 증가함에 따라 예측 기간 내에 시장이 엄청나게 성장합니다. 게다가 호흡기 질환의 지속적인 급증으로 인해 향후 몇 년 동안 점액선모 청소 및 기능 장애 치료 시장이 눈에 띄는 속도로 성장할 것으로 예상됩니다.

• Data Bridge Market Research는 점액선조 청소 및 기능 장애 치료 시장이 2021년에 6억 200만 달러로 평가되었으며, 2029년까지 9억 6,676만 달러에 도달할 것으로 예상되며, 2022-2029년 예측 기간 동안 6.10%의 CAGR을 기록할 것으로 분석했습니다. "병원"은 예측 기간 동안 점액선조 청소 및 기능 장애 치료 시장에서 가장 큰 최종 사용자 세그먼트를 차지합니다.

글로벌 점액선모 청소 및 기능 장애 치료 시장 정의

점액선모기능장애는 만성폐쇄성폐질환 의 흔한 징후입니다 . 점액선모청소는 코를 통해 흡입되는 미생물과 자극물에 대한 잘 알려진 선천적 방어 시스템입니다. 비강-비강 시스템의 사카린 검사를 사용하여 점액선모청소를 평가할 수 있습니다. 점액선모청소를 위한 요법에는 일반적으로 점액 점도를 줄이기 위한 단백질 분해 효소, 섬모 박동 빈도를 개선하기 위한 진동, 섬모 빈도를 위한 Locke-Ringer 용액으로 관개, 글루코스테로이드 및 계면활성제가 포함됩니다.

점액선모 청소 및 기능 장애 치료 시장 동향

운전자

• 호흡기 질환의 증가 사례 

만성 폐쇄성 폐질환(COPD) 및 천식과 같은 호흡기 질환은 전 세계적으로 치료 시장 성장률을 확대할 것입니다.

Moreover, the adoption of unhealthy lifestyle and rising number of vaccines in pipeline are also the growth determinants that bolster the market's growth. Also, the developments in healthcare technology will further enhance the growth of mucociliary clearance and dysfunction treatment market. Furthermore, the rising initiatives to spread awareness regarding the respiratory disease is the factor that will expand the mucociliary clearance and dysfunction treatment market. The new therapies and treatment for management of mucociliary clearance will positively impact the mucociliary clearance and dysfunction treatment market's growth rate.

Opportunities

Moreover, the advancements in technology and availability of new therapies and medical devices for treatment will boost new opportunities for the market's growth rate. Also, the increased awareness regarding the treatment and ongoing clinical trials will escalate the growth rate mucociliary clearance and dysfunction treatment market in future.

Restraints/Challenges Global Mucociliary Clearance and Dysfunction Treatment Market

However, the low awareness about the available treatment will impede the growth rate of mucociliary clearance and dysfunction treatment market. Additionally, the lack in research and development in the related field is projected to hamper market growth.

This mucociliary clearance and dysfunction treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on mucociliary clearance and dysfunction treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The mucociliary dysfunction is a common sign of chronic obstructive pulmonary disease. Chronic airway mucus hypersecretion can cause COPD patients' pulmonary function to deteriorate over time. According to research, COPD was found to be prevalent in 3.6 percent of our adult population (aged 45 years) and increased dramatically with age (1.9 percent in 45–64 years, 4.8 percent in 65–74 years, 6.8 percent in 75–84 years, and 5.6 percent in 85 years).

Mucociliary clearance and dysfunction treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Mucociliary Clearance and Dysfunction Treatment Market

Healthcare and pharmaceutical industries were heavily impacted by the COVID-19. However, the mucociliary clearance and dysfunction treatment market was affected largely by the sudden emergence of the COVID-19. The isolation regulations across the globe further disrupted the supply chain and even caused delays in the import and export of drugs and medicines for the mucociliary clearance causing a negative impact on the market. On the flip side, the people suffering from various respiratory diseases such as COPD and interstitial lung disease had high chances of contracting coronavirus, which causes mucociliary dysfunction and increases the demand for mucociliary clearance and dysfunction treatment, resulting in a higher demand in increase in the growth of the market.

Recent Developments

• In July 2021, The US Food and Drug Administration has accepted AstraZeneca's Biologics License Application (BLA) for tezepelumab and granted it Priority Review for the treatment of asthma (FDA). AstraZeneca Plc is developing Tezepelumab in collaboration with Amgen Inc.

Global Mucociliary Clearance and Dysfunction Treatment Market Scope

The mucociliary clearance and dysfunction treatment market is segmented on the basis of treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Medications
• Surgery
• Mucus Clearance Device
• Others

On the basis of treatment, mucociliary clearance and dysfunction treatment market is segmented into medications, surgery, mucus clearance device and others. Medications can be further segmented into expectorants, mucoregulators, mucolytics and others.

Route of Administration

• Oral
• Inhalation
• Others

On the basis of route of administration, the mucociliary clearance and dysfunction treatment market is segmented into oral, inhalation and others.

End-Users

• Hospitals
• Specialty Clinics
• Others

On the basis of end-users, the mucociliary clearance and dysfunction treatment market is segmented into hospitals, specialty clinics and others. Hospitals dominates the segment in the mucociliary clearance and dysfunction treatment market.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

On the basis of distribution channel, the mucociliary clearance and dysfunction treatment market is segmented into hospital pharmacy, retail pharmacy and others.

Mucociliary Clearance and Dysfunction Treatment Market Regional Analysis/Insights

The mucociliary clearance and dysfunction treatment market is analyzed and market size insights and trends are provided by country, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the mucociliary clearance and dysfunction treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific dominates the mucociliary clearance and dysfunction treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period owing to the increasing prevalence of respiratory diseases and huge investment in research and development in this region.

North America on the other hand is projected to exhibit the highest growth rate during the forecast period due to the presence of advanced of technology and focus of global players on novel technology in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Mucociliary Clearance and Dysfunction Treatment Market Share Analysis

점액선모 청소 및 기능 장애 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 점액선모 청소 및 기능 장애 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

점액선모 청소 및 기능 장애 치료 시장에서 활동하는 주요 기업으로는 VORTRAN Medical Technology 1 Inc., Smiths Group plc, Monaghan, Hill-Rom Services Inc., Allergan, Novartis AG, AstraZeneca, Merck KGaA, Regeneron Pharmaceuticals Inc., Abbott, F. Hoffmann-La Roche Ltd., Cadila Pharmaceuticals, Eisai Co., Ltd., Cipla Inc., Glenmark Pharmaceuticals Limited, Vertical Pharmaceuticals, LLC, TORAY INDUSTRIES, INC., Pfizer Inc. 등이 있습니다.

연구 방법론: 글로벌 점액선모 청소 및 기능 장애 치료 시장

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭 다운하세요. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의 사항을 드롭하여 업계 전문가에게 문의하세요  https://www.databridgemarketresearch.com/ko/speak-to-analyst/?dbmr=global-mucociliary-clearance-and-dysfunction-treatment-market

SKU-52910